D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 57 Citations 16,768 271 World Ranking 2381 National Ranking 37

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Virus

Immunology, Internal medicine, Chlamydia trachomatis, Virology and Gynecology are his primary areas of study. Lars Østergaard combines subjects such as Receptor and Case-control study with his study of Immunology. His study in Case-control study is interdisciplinary in nature, drawing from both Malignancy, Acquired immunodeficiency syndrome, microRNA, Essential hypertension and Cohort.

His Internal medicine research is multidisciplinary, relying on both Gastroenterology, Surgery, Oncology and Vaccination. His studies in Chlamydia trachomatis integrate themes in fields like Nucleic acid amplification technique, Chlamydia, Randomized controlled trial and Genitourinary system. The concepts of his Virology study are interwoven with issues in RNA and IRF3.

His most cited work include:

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study (2421 citations)
  • Maternal Infection Requiring Hospitalization During Pregnancy and Autism Spectrum Disorders (559 citations)
  • Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial (403 citations)

What are the main themes of his work throughout his whole career to date?

Lars Østergaard spends much of his time researching Immunology, Internal medicine, Virology, Chlamydia trachomatis and Cohort study. Antibody, Immune system, Vaccination, Innate immune system and Inflammation are the primary areas of interest in his Immunology study. His Internal medicine research incorporates themes from Gastroenterology, Surgery and Intensive care medicine.

The study incorporates disciplines such as Chlamydia and Obstetrics in addition to Chlamydia trachomatis. His Cohort study research is multidisciplinary, incorporating elements of Epidemiology, Incidence, Hazard ratio, Pediatrics and Cohort. His research in Randomized controlled trial intersects with topics in Placebo and Physical therapy.

He most often published in these fields:

  • Immunology (38.36%)
  • Internal medicine (26.58%)
  • Virology (18.63%)

What were the highlights of his more recent work (between 2015-2021)?

  • Immunology (38.36%)
  • Internal medicine (26.58%)
  • Immune system (10.14%)

In recent papers he was focusing on the following fields of study:

Lars Østergaard mainly focuses on Immunology, Internal medicine, Immune system, Virology and Antibody. His studies link Receptor with Immunology. As part of his studies on Internal medicine, Lars Østergaard frequently links adjacent subjects like Surgery.

His study in the field of CD8, T cell, Immunity and Acquired immune system also crosses realms of Cart. His T cell research focuses on Cancer research and how it connects with Lymph. His work deals with themes such as Cervarix, Gardasil and In vivo, which intersect with Virology.

Between 2015 and 2021, his most popular works were:

  • Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study (249 citations)
  • Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial (108 citations)
  • Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial (108 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Virus
  • Disease

His primary areas of study are Immunology, Virology, Immune system, CD8 and Panobinostat. He has included themes like Agonist and Receptor in his Immunology study. His study explores the link between Virology and topics such as In vivo that cross with problems in Viral replication, Vagina and Transmission.

His CD8 study combines topics in areas such as T cell, Cancer research and Cytokine. Lars Østergaard usually deals with Innate immune system and limits it to topics linked to Cytotoxic T cell and Virus latency. His work in the fields of Immunogenicity overlaps with other areas such as Papillomavirus Vaccines.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka.
PLOS ONE (2015)

4699 Citations

Maternal Infection Requiring Hospitalization During Pregnancy and Autism Spectrum Disorders

Hjördis Ó. Atladóttir;Poul Thorsen;Lars Østergaard;Diana E. Schendel.
Journal of Autism and Developmental Disorders (2010)

891 Citations

Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial

Thomas A Rasmussen;Martin Tolstrup;Christel R Brinkmann;Rikke Olesen.
The Lancet HIV (2014)

708 Citations

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

Alison J Rodger;Valentina Cambiano;Tina Bruun;Pietro Vernazza.
The Lancet (2019)

589 Citations

The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo.

Ole S. Søgaard;Mette E. Graversen;Steffen Leth;Rikke Olesen.
PLOS Pathogens (2015)

470 Citations

Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae.

Robert L. Cook;Shari L. Hutchison;Lars Østergaard;R. Scott Braithwaite.
Annals of Internal Medicine (2005)

446 Citations

Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis

Jonathan Z. Li;Roger Paredes;Heather J. Ribaudo;Evguenia S. Svarovskaia.
JAMA (2011)

389 Citations

IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication

Martin R. Jakobsen;Rasmus O. Bak;Annika Andersen;Randi K. Berg;Randi K. Berg.
Proceedings of the National Academy of Sciences of the United States of America (2013)

318 Citations

Comparison of HDAC inhibitors in clinical development: effect on HIV production in latently infected cells and T-cell activation.

Thomas Aagaard Rasmussen;Ole Schmeltz Sogaard;Christel Brinkmann;Fiona Wightman.
Human Vaccines & Immunotherapeutics (2013)

255 Citations

Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns

Trine H. Mogensen;Søren R. Paludan;Mogens Kilian;Lars Østergaard.
Journal of Leukocyte Biology (2006)

247 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Lars Østergaard

Sharon R. Lewin

Sharon R. Lewin

University of Melbourne

Publications: 82

Nicola Low

Nicola Low

University of Bern

Publications: 43

Alberto Mantovani

Alberto Mantovani

Humanitas University

Publications: 39

Robert F. Siliciano

Robert F. Siliciano

Johns Hopkins University School of Medicine

Publications: 37

David M. Margolis

David M. Margolis

University of North Carolina at Chapel Hill

Publications: 36

Søren R. Paludan

Søren R. Paludan

Aarhus University

Publications: 36

Steven G. Deeks

Steven G. Deeks

University of California, San Francisco

Publications: 35

Lars Bo Andersen

Lars Bo Andersen

University of Bergen

Publications: 32

Paul R. Gorry

Paul R. Gorry

RMIT University

Publications: 32

Roger Paredes

Roger Paredes

University of Vic

Publications: 31

Peter Aaby

Peter Aaby

University of Copenhagen

Publications: 31

Christopher K. Fairley

Christopher K. Fairley

Monash University

Publications: 31

Cecilia Garlanda

Cecilia Garlanda

Humanitas University

Publications: 28

Shen-Ying Zhang

Shen-Ying Zhang

Rockefeller University

Publications: 26

Laurent Abel

Laurent Abel

Université Paris Cité

Publications: 26

Douglas D. Richman

Douglas D. Richman

University of California, San Diego

Publications: 26

Trending Scientists

Narjess Boubakri

Narjess Boubakri

American University of Sharjah

Peter Müller

Peter Müller

The University of Texas at Austin

Robert M. Jopson

Robert M. Jopson

Nokia (United States)

Juan C. Fontecilla-Camps

Juan C. Fontecilla-Camps

Centre national de la recherche scientifique, CNRS

Martin Eickhoff

Martin Eickhoff

University of Bremen

Luca Scorrano

Luca Scorrano

University of Padua

Martin E. Feder

Martin E. Feder

University of Chicago

Bruce D. Carter

Bruce D. Carter

Vanderbilt University

Michel R. Popoff

Michel R. Popoff

Institut Pasteur

William T. Frankenberger

William T. Frankenberger

University of California, Riverside

Valérie Doyère

Valérie Doyère

University of Paris-Saclay

Barry E. Stein

Barry E. Stein

Wake Forest University

Gary A. Ford

Gary A. Ford

University of Oxford

Henian Chen

Henian Chen

University of South Florida

Andrew J. King

Andrew J. King

University of Leicester

Something went wrong. Please try again later.